Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:1767-1774

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuominen, S.
Right arrow Articles by Kalimo, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuominen, S.
Right arrow Articles by Kalimo, H.
Related Collections
Right arrow Clinical genetics
Right arrow Gene expression
Right arrow CT and MRI
Right arrow Nuclear cardiology and PET
Right arrow Genetics of Stroke
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow PET and SPECT
Right arrow Genetics of cardiovascular disease
Right arrow Other Vascular biology

(Stroke. 2001;32:1767.)
© 2001 American Heart Association, Inc.


Original Contributions

Phenotype of a Homozygous CADASIL Patient in Comparison to 9 Age-Matched Heterozygous Patients With the Same R133C Notch3 Mutation

Susanna Tuominen, MD; Vesa Juvonen, MSc; Kaarina Amberla, MSc; Tapani Jolma, MD; Juha O. Rinne, MD, PhD; Seppo Tuisku, MD; Timo Kurki, MD, PhD; Reijo Marttila, MD, PhD; Minna Pöyhönen, MD, PhD; Marja-Liisa Savontaus, PhD; Matti Viitanen, MD, PhD Hannu Kalimo, MD, PhD

From the Departments of Neurology (S.T., R.M.), Radiology (T.K.), and Pathology (H.K.), Turku University Hospital and University of Turku (Finland); Department of Medical Genetics, University of Turku (Finland) (V.J., M-L.S.); Division of Geriatric Medicine, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden (K.A., M.V.); Department of Neurology, Satakunta Central Hospital, Pori, Finland (T.J.); Turku PET Center (Finland) (J.O.R.); Department of Neurology, Keski-Pohjanmaa Central Hospital, Kokkola, Finland (S.T.); and Department of Medical Genetics, Family Federation of Finland, Helsinki (M.P.). Drs Tuominen and Juvonen have contributed equally to this study.

Correspondence to Hannu Kalimo, MD, Turku University Hospital and University of Turku, Department of Pathology, FIN-20520 Turku, Finland. E-mail hkalimo{at}utu.fi

Background and Purpose— CADASIL is an autosomal dominant arteriopathy, characterized by multiple brain infarcts, cognitive decline, and finally dementia, which is caused by mutations in Notch3 gene encoding a Notch3 receptor protein. We describe the clinical, neuropsychological, imaging, genetic, and skin biopsy findings in a CADASIL patient homozygous for the C475T mutation resulting in R133C amino acid substitution, in comparison to 9 age-matched heterozygous patients with the same mutation.

Methods— The patients were examined clinically and neuropsychologically and with MRI and positron emission tomography for assessment of cerebral blood flow. The gene defect was analyzed by sequencing the products of polymerase chain reaction of exons 3 and 4 of the Notch3 gene. Dermal arteries were analyzed electron microscopically.

Results— The homozygous patient had his first-ever stroke at age 28 years. This is markedly earlier than the average, but the patient’s heterozygous son had his first transient ischemic attack–like episode at the same age and another heterozygous patient had his first-ever stroke when only 2 years older. He was neuropsychologically more severely deteriorated than all but 1 of the heterozygous patients. These 2 patients had the most severe (confluent grade D) white matter MRI changes. Positron emission tomography showed markedly reduced cerebral blood flow. Skin biopsy revealed profuse deposits of granular osmiophilic material. The progression of disease in the homozygous case was, however, slower than in the most severely affected heterozygous patient.

Conclusions— Our homozygous patient’s phenotype is within the clinical spectrum of CADASIL, although at its severe end. Thus, CADASIL may follow the classic definition of a dominant disease, according to which the heterozygous and homozygous patients are clinically indistinguishable.


Key Words: CADASIL • dementia, vascular • homozygote • magnetic resonance imaging • neuropsychological tests • tomography, emission computed




This article has been cited by other articles:


Home page
StrokeHome page
Q. Miao, T. Paloneva, S. Tuisku, S. Roine, M. Poyhonen, M. Viitanen, and H. Kalimo
Arterioles of the Lenticular Nucleus in CADASIL
Stroke, September 1, 2006; 37(9): 2242 - 2247.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Dubroca, P. Lacombe, V. Domenga, J. Maciazek, B. Levy, E. Tournier-Lasserve, A. Joutel, and D. Henrion
Impaired Vascular Mechanotransduction in a Transgenic Mouse Model of CADASIL Arteriopathy
Stroke, January 1, 2005; 36(1): 113 - 117.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Tuominen, Q. Miao, T. Kurki, S. Tuisku, M. Poyhonen, H. Kalimo, M. Viitanen, H. T. Sipila, J. Bergman, and J. O. Rinne
Positron Emission Tomography Examination of Cerebral Blood Flow and Glucose Metabolism in Young CADASIL Patients
Stroke, May 1, 2004; 35(5): 1063 - 1067.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Tatsch, W. Koch, R. Linke, G. Poepperl, N. Peters, M. Holtmannspoetter, and M. Dichgans
Cortical Hypometabolism and Crossed Cerebellar Diaschisis Suggest Subcortically Induced Disconnection in CADASIL: An 18F-FDG PET Study
J. Nucl. Med., June 1, 2003; 44(6): 862 - 869.
[Abstract] [Full Text] [PDF]